ABIOMED, Inc.‘s (ABMD) share price has entered into oversold territory with a stochastic value of 5.943. The Zacks Consensus Estimate on the company’s earnings for year ending March 2012 increased by 8 cents over the past month to 1 cent per share. ABIOMED, Inc is a Zacks #2 Rank (“Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
